宁红欣与利血宝治疗肾性贫血的疗效

A COMPARATIVE STUDY OF NINGHONGXIN AND LIXUEBAO IN THE TREATMENT OF RENAL ANEMIA

目的比较宁红欣 (国产红细胞生成素 )和利血宝治疗肾性贫血的临床疗效。方法选择肾性贫血 12 0例 ,随机分为宁红欣 (2 0 0 0U ,皮下注射 ,每周 3次 )治疗组 6 0例和利血宝 (30 0 0U ,皮下注射 ,每周 2次 )对照组 6 0例 ,均治疗 12周。结果与治疗前比较 ,宁红欣总有效率 86 .7% ,显效率 5 5 .0 %。利血宝总有效率 85 .0 % ,显效率 5 0 .0 %。两组间上述参数在治疗前、治疗后 4、8、12周均无统计学差异 (P >0 .0 5 )。结论宁红欣治疗肾性贫血与利血宝疗效基本相当。

ObjectiveTo compare the efficacy of Ninghongxin(a kind of domestic rhu EPO) and Lixuebao in treatment of renal anemia.Methods120 patients with renal anemia were randomly divided to receive Ninghongxin (n=60) in a dose of 2000U,three times every week for 12 weeks, and Lixuebao (n=60) in a dose of 3000U,twice every week for 12 weeks.ResultsAfter treatment, the total effective rate of Ninghongxin was 86.7 % ,the effective rate was 55 %.The total effective rate of Lixuebao was 85 %, the effective rate was 50 %.There is no significant difference between all parameters of the two groups.ConclusionThe study showed that the efficacy of Ninghongxin in the treatment of renal anemia is as effective as those of Lixuebao in doses stated above.